{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:00:02Z","timestamp":1790413202502,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008963","name":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["CCR13262449"],"award-info":[{"award-number":["CCR13262449"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["ISCIII-PI13\/01718"],"award-info":[{"award-number":["ISCIII-PI13\/01718"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018779","name":"Fundaci\u00f3n Fero","doi-asserted-by":"publisher","award":["CP14\/0028"],"award-info":[{"award-number":["CP14\/0028"]}],"id":[{"id":"10.13039\/501100018779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018779","name":"Fundaci\u00f3n Fero","doi-asserted-by":"publisher","award":["PI13\/01714"],"award-info":[{"award-number":["PI13\/01714"]}],"id":[{"id":"10.13039\/501100018779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIE13\/00022"],"award-info":[{"award-number":["PIE13\/00022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["SAF2008-01975"],"award-info":[{"award-number":["SAF2008-01975"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["SAF2011-22893"],"award-info":[{"award-number":["SAF2011-22893"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["SAF2014-55997"],"award-info":[{"award-number":["SAF2014-55997"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005142","name":"Banco Bilbao Vizcaya Argentaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007406","name":"Fundaci\u00f3n BBVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.stemcr.2017.03.026","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T12:04:33Z","timestamp":1493294673000},"page":"1392-1407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population"],"prefix":"10.1016","volume":"8","author":[{"given":"Jorge","family":"G\u00f3mez-Miragaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palafox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Yoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"P\u00e9rez-Montoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Igea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel R.","family":"Nebreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Urruticoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Soler-Monso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2017.03.026_bib1","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2017.03.026_bib2","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/bcr3061","article-title":"Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance","volume":"13","author":"Ali","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib3","doi-asserted-by":"crossref","first-page":"vi46","DOI":"10.1093\/annonc\/mds195","article-title":"Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents","volume":"23","author":"Andre","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/stem.435","article-title":"The CD10 enzyme is a key player to identify and regulate human mammary stem cells","volume":"28","author":"Bachelard-Cascales","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2017.03.026_bib5","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","article-title":"Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer","volume":"295","author":"Berry","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.stemcr.2017.03.026_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1470-2045(11)70094-8","article-title":"TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994\/BIG 1-00): a randomised phase 3 trial","volume":"12","author":"Bonnefoi","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cell.2016.08.041","article-title":"A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds","volume":"167","author":"Bruna","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2017.03.026_bib8","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","article-title":"Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis","volume":"34","author":"Clarke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.stemcr.2017.03.026_bib9","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1158\/1078-0432.CCR-04-0380","article-title":"Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment","volume":"10","author":"Colleoni","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature11814","article-title":"Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance","volume":"494","author":"Das Thakur","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stemcr.2017.03.026_bib12","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nm.2454","article-title":"Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes","volume":"17","author":"DeRose","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2017.03.026_bib13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2010.31.2231","article-title":"Multifactorial approach to predicting resistance to anthracyclines","volume":"29","author":"Desmedt","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10555-016-9653-x","article-title":"Patient-derived xenograft (PDX) models in basic and translational breast cancer research","volume":"35","author":"Dobrolecki","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.stemcr.2017.03.026_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature13952","article-title":"Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution","volume":"518","author":"Eirew","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib16","first-page":"901","article-title":"High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival","volume":"55","author":"Friedrichs","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1200\/JCO.2005.02.6914","article-title":"Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors","volume":"24","author":"Guarneri","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3892\/ijo.2013.1955","article-title":"CD49f-positive cell population efficiently enriches colon cancer-initiating cells","volume":"43","author":"Haraguchi","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib19","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.2011.593","article-title":"A\u00a0genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer","volume":"305","author":"Hatzis","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.stemcr.2017.03.026_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1741-7015-7-9","article-title":"A compact VEGF signature associated with distant metastases and poor outcomes","volume":"7","author":"Hu","year":"2009","journal-title":"BMC Med."},{"key":"10.1016\/j.stemcr.2017.03.026_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000322192","article-title":"Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer","volume":"79","author":"Kim","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.stemcr.2017.03.026_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.stemcr.2017.03.026_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm.2000","article-title":"Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers","volume":"15","author":"Lim","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2017.03.026_bib24","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/onc.2011.439","article-title":"CD49f and CD61 identify Her2\/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling","volume":"31","author":"Lo","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2017.03.026_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-011-1461-y","article-title":"Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer","volume":"128","author":"Martin","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.stemcr.2017.03.026_bib26","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1158\/0008-5472.CAN-09-3619","article-title":"CD44posCD49fhiCD133\/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer","volume":"70","author":"Meyer","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib29","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12916-015-0540-z","article-title":"Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy","volume":"13","author":"Prat","year":"2015","journal-title":"BMC Med."},{"issue":"Suppl 2","key":"10.1016\/j.stemcr.2017.03.026_bib31","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.stemcr.2017.03.026_bib32","doi-asserted-by":"crossref","first-page":"e17911","DOI":"10.1371\/journal.pone.0017911","article-title":"GOBO: gene expression-based outcome for breast cancer online","volume":"6","author":"Ringner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2017.03.026_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-59745-019-5_11","article-title":"Isolation, culture and analysis of mouse mammary epithelial cells","volume":"633","author":"Smalley","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.stemcr.2017.03.026_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature04496","article-title":"Purification and unique properties of mammary epithelial stem cells","volume":"439","author":"Stingl","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2017.03.026_bib37","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2017.03.026_bib38","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1038\/onc.2013.516","article-title":"A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer","volume":"33","author":"Vassilopoulos","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2017.03.026_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4048\/jbc.2015.18.3.242","article-title":"The presence of EpCAM(-)\/CD49f(+) cells in breast cancer is associated with a poor clinical outcome","volume":"18","author":"Ye","year":"2015","journal-title":"J.\u00a0Breast Cancer"},{"key":"10.1016\/j.stemcr.2017.03.026_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2017.03.026_bib41","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-2986","article-title":"Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stemcr.2017.03.026_bib42","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-12-4081","article-title":"A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671117301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671117301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:38:48Z","timestamp":1761989928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671117301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213671117301339"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2017.03.026","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2017.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}